Buy RESTYLANE SKINBOOSTER Lidocaïne (1x1ml)
– RESTYLANE SKINBOOSTER Lidocaine is the ideal product to rejuvenate mature and photodamaged skin.
– From the first session, you will notice a radiant, harmonious and natural complexion for a stable and long-lasting effect.
– This product is used to reshape the skin of the décolleté, but also the face, hands and neck.
– RESTYLANE SKINBOOSTER is injected by your practitioner.
– RESTYLANE SKINBOOSTER combines two important qualities to ensure a product that respects your skin: a harmonious hydration and a protective layer to keep your skin glowing.
Results
– After treatment, patients notice:
- More hydrated and supple skin
- A more radiant complexion
- Reduction in fine lines
- Results last up to 2 months on average
– Touch-ups can be performed after treatment to enhance the results previously achieved.
– Maintenance sessions can also be scheduled to maintain the desired effects over time.
Targeted Areas
This gel can be used on the following areas:
- Face
- Neck
- Cleavage
- Back of the hands
- Arms
Composition
- HA concentration: 12 mg/ml.
- Cross-linked hyaluronic acid.
- Lidocaine (0.3%)
- Physiological solution of sodium chloride, pH 7
- Syringe and needle 30G x 1/2
Application protocol
- RESTYLANE SKINBOOSTER must be injected into the superficial dermis.
- It is a medical device that must be administered only by a professional authorized to inject hyaluronic acid fillers.
- This product can be used with a needle, a cannula or with a hyaluron pen (accessories are available in our store, needles are included in the box).
Contraindicated
– For a safe treatment, the doctor of your choice will have to determine with you and according to your medical file if you can use the filling products of the Galderma Laboratory.
– The use of this product is not recommended in the following cases:
- Allergy to the components present in the product.
- Pregnant or breastfeeding women
- Minors
- Injection in areas with skin problems (infection, inflammation)
Reviews
There are no reviews yet.